JPWO2020207991A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020207991A5 JPWO2020207991A5 JP2021559754A JP2021559754A JPWO2020207991A5 JP WO2020207991 A5 JPWO2020207991 A5 JP WO2020207991A5 JP 2021559754 A JP2021559754 A JP 2021559754A JP 2021559754 A JP2021559754 A JP 2021559754A JP WO2020207991 A5 JPWO2020207991 A5 JP WO2020207991A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hexahydro
- pyrazino
- amino
- carbonitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019081900 | 2019-04-09 | ||
| CNPCT/CN2019/081900 | 2019-04-09 | ||
| CN2019121598 | 2019-11-28 | ||
| CNPCT/CN2019/121598 | 2019-11-28 | ||
| CNPCT/CN2020/078225 | 2020-03-06 | ||
| CN2020078225 | 2020-03-06 | ||
| PCT/EP2020/059831 WO2020207991A1 (en) | 2019-04-09 | 2020-04-07 | Hexahydro-1h-pyrazino[1,2-a]pyrazine compounds for the treatment of autoimmune disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527588A JP2022527588A (ja) | 2022-06-02 |
| JPWO2020207991A5 true JPWO2020207991A5 (hr) | 2023-04-10 |
Family
ID=70228042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559754A Pending JP2022527588A (ja) | 2019-04-09 | 2020-04-07 | 自己免疫疾患の治療のためのヘキサヒドロ－１Ｈ－ピラジノ［１，２－ａ］ピラジン化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20220340597A1 (hr) |
| EP (1) | EP3953356B1 (hr) |
| JP (1) | JP2022527588A (hr) |
| KR (1) | KR20210149163A (hr) |
| CN (1) | CN113710672A (hr) |
| AU (1) | AU2020272467A1 (hr) |
| BR (1) | BR112021020297A2 (hr) |
| CA (1) | CA3135129A1 (hr) |
| CL (1) | CL2021002621A1 (hr) |
| CO (1) | CO2021013166A2 (hr) |
| CR (1) | CR20210513A (hr) |
| IL (1) | IL286870A (hr) |
| MA (1) | MA55594A (hr) |
| MX (1) | MX2021012223A (hr) |
| PE (1) | PE20212178A1 (hr) |
| SG (1) | SG11202110401WA (hr) |
| TW (1) | TW202104230A (hr) |
| WO (1) | WO2020207991A1 (hr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230034723A1 (en) * | 2019-10-31 | 2023-02-02 | Hoffmann-La Roche Inc. | Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease |
| JP2023500733A (ja) * | 2019-11-12 | 2023-01-10 | エフ．ホフマン－ラ ロシュ アーゲー | 自己免疫疾患の処置のためのヒドロピラジノ［１，２－ｂ］イソキノリン化合物 |
| WO2021110614A1 (en) * | 2019-12-03 | 2021-06-10 | F. Hoffmann-La Roche Ag | HYDROPYRIDO[1,2-α]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE |
| EP4182032A1 (en) * | 2020-07-14 | 2023-05-24 | F. Hoffmann-La Roche AG | Hydroisoquinoline or hydronaphthyridine compounds for the treatment of autoimmune disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2663555T4 (pl) * | 2011-01-12 | 2017-08-31 | Ventirx Pharmaceuticals, Inc. | Podstawione benzoazepiny jako modulatory receptora toll-podobnego |
| NZ705154A (en) | 2012-09-14 | 2018-03-23 | Hoffmann La Roche | Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson’s disease |
| US9643967B2 (en) * | 2013-12-13 | 2017-05-09 | Takeda Pharmaceutical Company Limited | Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors |
| MY196319A (en) * | 2015-12-17 | 2023-03-24 | Merck Patent Gmbh | Polycyclic TLR7/8 Antagonists and use Thereof in the Treatment of Immune Disorders |
| CN112585134A (zh) * | 2018-06-13 | 2021-03-30 | 豪夫迈·罗氏有限公司 | 用于治疗自身免疫性疾病的吡啶基杂环基化合物 |
| JP2022501401A (ja) * | 2018-09-27 | 2022-01-06 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 自己免疫疾患の治療のためのヘテロシクリル化合物 |
-
2020
- 2020-04-07 CA CA3135129A patent/CA3135129A1/en active Pending
- 2020-04-07 WO PCT/EP2020/059831 patent/WO2020207991A1/en active Application Filing
- 2020-04-07 JP JP2021559754A patent/JP2022527588A/ja active Pending
- 2020-04-07 US US17/602,057 patent/US20220340597A1/en active Pending
- 2020-04-07 SG SG11202110401WA patent/SG11202110401WA/en unknown
- 2020-04-07 MX MX2021012223A patent/MX2021012223A/es unknown
- 2020-04-07 PE PE2021001647A patent/PE20212178A1/es unknown
- 2020-04-07 CN CN202080030189.2A patent/CN113710672A/zh active Pending
- 2020-04-07 AU AU2020272467A patent/AU2020272467A1/en not_active Abandoned
- 2020-04-07 CR CR20210513A patent/CR20210513A/es unknown
- 2020-04-07 EP EP20717841.9A patent/EP3953356B1/en active Active
- 2020-04-07 MA MA055594A patent/MA55594A/fr unknown
- 2020-04-07 BR BR112021020297A patent/BR112021020297A2/pt not_active Application Discontinuation
- 2020-04-07 KR KR1020217036391A patent/KR20210149163A/ko unknown
- 2020-04-08 TW TW109111749A patent/TW202104230A/zh unknown
-
2021
- 2021-09-30 CO CONC2021/0013166A patent/CO2021013166A2/es unknown
- 2021-09-30 IL IL286870A patent/IL286870A/en unknown
- 2021-10-06 CL CL2021002621A patent/CL2021002621A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11591336B2 (en) | Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors | |
| HRP20180080T1 (hr) | Pirimidopirimidinoni korisni kao inhibitori wee-1 kinaze | |
| JP2019535664A5 (hr) | ||
| RU2019115115A (ru) | Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7 | |
| JP5911638B2 (ja) | ベンゾチアゾール−６−イル酢酸誘導体およびｈｉｖ感染を処置するためのそれらの使用 | |
| JPWO2020081848A5 (hr) | ||
| EP4093406A1 (en) | Enhancement of anti-tumor activity of shp2 inhibitor pyrimidinone in combination with novel cancer medicines in cancers | |
| CN105294683A (zh) | Cdk类小分子抑制剂的化合物及其用途 | |
| KR20130006625A (ko) | Ｃｄｋ4/6의 억제제로서의 피롤로피리미딘 화합물 | |
| CN105294681A (zh) | Cdk类小分子抑制剂的化合物及其用途 | |
| TW201219398A (en) | Furo[3,2-d]pyrimidine compounds | |
| JP2020510092A5 (hr) | ||
| RU2012131129A (ru) | Соединения замещенного n-(1н-индазол-4-ил)имидазол[1,2-а]-3-карбоксамида как ингибиторы cfms | |
| JP2021526535A (ja) | 自己免疫疾患の処置のための新規のヘテロアリールヘテロシクリル化合物 | |
| RU2014151004A (ru) | Пирролопиримидоновые и пирролопиридоновые ингибиторы танкиразы | |
| ES2967432T3 (es) | Compuestos de imidazo[4,5-b]piridina y composiciones farmacéuticas de los mismos para el tratamiento de trastornos inflamatorios | |
| WO2022232332A1 (en) | 2-aminobenzothiazole compounds and methods of use thereof | |
| EP4237086A1 (en) | Heterocyclic spiro compounds and methods of use | |
| US20200079763A1 (en) | Quinoxaline and pyridopyrazine derivatives as a pi3kb inhibitors | |
| TW202321242A (zh) | 雜環化合物及使用方法 | |
| RU2012131115A (ru) | Ингибиторы активности акт | |
| JP2013515710A5 (hr) | ||
| JP2021506885A (ja) | マルチキナーゼ阻害剤としてのカルバメートおよび尿素化合物 | |
| JPWO2020207991A5 (hr) | ||
| JPWO2019233941A5 (hr) |